Neurological Disease
Developing lead compound series for neurodegenerative disorders, leveraging open science protocols and structural biology facilities.
Oncology Targets
Advancing novel small molecule and biologic candidates for resistant cancers, focusing on pre-competitive screening and assay optimization.
Uncompromising Scientific Rigor
Every validated molecule undergoes rigorous replication protocols, ensuring data integrity and reproducibility. Our commitment to scientific excellence guides each step of the translational pipeline.
We provide complete open-data packages for all validated compounds, detailing assay validation metrics and screening results. This transparency fosters collaborative research and accelerates discovery.
Initiate Co-Development
Explore structured co-development models designed to transition non-profit discoveries into clinical trials with institutional partners.